Edwards Lifesciences Corporatio Price Today
Edwards Lifesciences Corporatio
EW
Healthcare
$48.84B
💰
Market Cap
33.4
💸
Price to Earnings
$2.4
🎉
EPS
+81
🌳
ESG
Consensus Recommendations
Buy Consensus
Buy |
16 |
Strong Buy |
7 |
Hold |
14 |
Sell |
0 |
Strong Sell |
1 |
EW Price Forecast Target
79.5 👉 110.0 +38%
EW EPS Forecast
2.4 👉 2.9 +21%
Financials
Profit Margin
25 %
Revenue Growth
11.4 %
Dividend
$ 0
Held Percent
0.9% - Insiders
85.6% - Institutions
13.5% - Public
Major Fund Holders
-
💰 Blackrock Inc. $4.1B
-
💰 Vanguard Group Inc $4.1B
-
💰 State Street Corporation $2.1B
-
💰 Capital International Investors $2.0B
-
💰 Alliancebernstein L.P. $1.6B
Stock Ideas
George Soros Portfolio
George Soros is a legendary hedge fund manager who made history when he earned 1 billion in 1992 and became known as 'the Man Who Broke the Bank of England'. "With an estimated net worth of 14.2 billion, Soros is ranked 35th on the list of the world…Stephen Mandel Portfolio
Stephen Mandel is the founder and portfolio manager of Lone Pine Capital, one of the largest and most successful hedge funds. Employing rigorous fundamental analysis, Mandel searches globally for qualitatively excellent growth companies trading at r…Scott Ferguson Portfolio
With a strong background as a protégé of Bill Ackman, founder of Pershing Square Capital Management, Scott Ferguson has honed his skills and expertise in the art of activist investing. He possesses the ability to identify undervalued companies with …Seth Klarman Portfolio
Seth Klarman's investment prowess is exemplified by his exceptional track record. Since the inception of his fund until 2008, he achieved an impressive compound return-on-investment of 20%. This remarkable achievement showcases his astute investment…📮FAQ
Some Frequently Asked Questions.
The Edwards Lifesciences Corporatio industry is Medical Devices
The Edwards Lifesciences Corporatio sector is Healthcare
The Edwards Lifesciences Corporatio forecasted predicted Price to Earnings PE ratio is 27.6
The Edwards Lifesciences Corporatio Price to Earnings PE ratio is 33.4
The Market Capitalization of Edwards Lifesciences Corporatio is $48.84B
There are total of 602317391 float shares with 85.6% held by Institutions and 0.9% held by insiders
The MEdwards Lifesciences Corporatio forecasted Earnings per Share EPS is $2.9
The Edwards Lifesciences Corporatio Earnings per Share EPS is 2.4
The Edwards Lifesciences Corporatio company has $4303600000 gross profits with 25 profit margins
The Edwards Lifesciences Corporatio Earnings Growth is -0.231% with -0.244% quarterly earnings growth
The Edwards Lifesciences Corporatio Revenue is $5657099776 with 0.114 revenue growth
The price target for Edwards Lifesciences Corporatio stock is $110.0 for the high target and $75.0 for the low target
The consensus analyst recommendations for Edwards Lifesciences Corporatio is Buy, however the decision to buy or sell the stock should be entirely yours, as you are earning your own money and hence responsible on how to allocate and spend them.
The consensus analyst recommendations for Edwards Lifesciences Corporatio is Buy, with the following breakdown:
- Buy: 16
- Strong Buy: 7
- Hold: 14
- Sell: 0
- Strong Sell: 1
The Beta of Edwards Lifesciences Corporatio is 1.0
The dividend of Edwards Lifesciences Corporatio is $0
The dividend yield of Edwards Lifesciences Corporatio is 0%
The biggest institutional and mutual fund holders of Edwards Lifesciences Corporatio stock are
- Blackrock Inc.
- Vanguard Group Inc
- State Street Corporation
- Capital International Investors
The Edwards Lifesciences Corporatio ESG Score is 81, with the following breakdown:
- E: 2.86
- S: 8.85
- G: 7.63